• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

识别可提高印度药物安全和合理用药的干预措施。

Identifying interventions that improve medication safety & rational use of medicines in India.

机构信息

Clinical Studies and Trials Unit, Division of Development Research, Indian Council of Medical Research, New Delhi, India.

Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.

出版信息

Indian J Med Res. 2024 May;159(5):410-420. doi: 10.25259/ijmr_945_23.

DOI:10.25259/ijmr_945_23
PMID:39382419
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11463240/
Abstract

Background & objectives Medication-related harm is known to be the cause for about 1/10th of hospitalizations. Some estimates from India show that about 90 per cent of medicines consumed are inessential or irrational and contribute towards high out-of-pocket expenditure on health. In this context, the Indian Council of Medical Research in 2022 constituted a National Task Force (NTF) to explore possible solutions that could improve safe and rational use of medicines (SRUMs). The objective of this study was to identify research ideas in the field of SRUM through a survey of relevant stakeholders, and further to prioritize the research ideas using a pre-identified set of criteria. Methods The responses from the identified stakeholders were assessed using the Child Health and Nutrition Research Initiative method, which is an established research priority-setting methodology. First, the NTF asked for two to six research ideas from relevant Indian and global stakeholders on solutions to improve SRUM. The ideas were checked for duplicates, re-phrased where necessary and classified into various sub-themes. Subsequently, the research ideas were scored by Indian experts with relevant technical expertise using a pre-defined set of five criteria: innovativeness, effectiveness, translational value, answerability and applicability. Each research idea received from a stakeholder was assigned a score under each of the five criteria. The overall research priority score was calculated as a mean of all five criteria-specific scores and converted into a percentage. Results The final output of the prioritization process was a list of research ideas or questions, ranked by their scores. Total 209 unique ideas were received from 190 respondents, which were scored by 27 experts. The top three research topics on medication safety focused on cost-effective strategies for improving antimicrobial stewardship, safe use of poly-pharmacy in geriatric patients and drug take-back policy interventions. Regarding the rational use of medicine, the top three topics included testing mobile application-based antimicrobial stewardship interventions, development of diagnostics for antimicrobial resistance, and behavioural interventions. Interpretation & conclusions Several priority ideas found in this study also align with those of global priority, e.g., safe disposal practices and enhanced pharmacovigilance, rational use of medicines. Patient engagement, which underlines many of the top scoring ideas found in this study, is also inclined with the top research priorities reported by the WHO priority exercise on research into the safe use of medicines. However, to the best of our knowledge, this is the first such work from a low- and middle- income country on medication safety and rational use of medicines. The findings of this research priority-setting exercise can help to guide research for the development of policy-relevant and novel interventions to improve SRUM in India.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f68/11463240/26634d7bc3b4/IJMR-159-5-410-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f68/11463240/26634d7bc3b4/IJMR-159-5-410-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6f68/11463240/26634d7bc3b4/IJMR-159-5-410-g1.jpg
摘要

背景与目的

据了解,药物相关伤害是导致约十分之一住院治疗的原因。印度的一些估计显示,约 90%的消耗药物是不必要或不合理的,这导致了医疗保健方面的高额自付支出。在这种情况下,印度医学研究理事会于 2022 年成立了一个国家工作队(NTF),以探索可能有助于提高药物安全合理使用(SRUM)的解决方案。本研究的目的是通过调查相关利益攸关方,确定 SRUM 领域的研究思路,并使用预先确定的一套标准对研究思路进行优先排序。

方法

通过使用既定的研究重点制定方法——儿童健康和营养研究倡议方法,对确定的利益攸关方的回复进行评估。首先,NTF 向相关的印度和全球利益攸关方询问了改善 SRUM 的解决方案,要求他们提出两到六个研究思路。对思路进行重复项检查,必要时重新措辞,并分为不同的子主题。随后,印度专家使用预先确定的五套标准对具有相关技术专长的研究思路进行评分:创新性、有效性、转化价值、可回答性和适用性。每个利益攸关方提出的研究思路在五个标准下都有一个得分。从每个利益攸关方收到的研究思路的总体研究优先级分数是所有五个标准特定分数的平均值,并转换为百分比。

结果

优先排序过程的最终结果是一份按分数排序的研究思路或问题清单。从 190 位受访者那里共收到 209 个独特的想法,由 27 位专家进行评分。药物安全方面的前三个研究主题集中在提高抗菌药物管理的成本效益策略、老年患者多药物安全使用和药品回收政策干预上。关于合理用药,前三个主题包括测试基于移动应用的抗菌药物管理干预措施、开发针对抗生素耐药性的诊断方法和行为干预。

结论与解释

本研究中的一些优先研究思路也与全球优先事项一致,例如安全处置做法和加强药物警戒、合理使用药物。患者参与,这也是本研究中许多得分较高的研究思路的基础,也与世界卫生组织关于安全使用药物的研究优先事项报告中的最高研究重点相一致。然而,据我们所知,这是来自中低收入国家的第一个关于药物安全和合理用药的此类工作。本研究重点制定工作的结果可以帮助指导研究,制定与政策相关的创新干预措施,以改善印度的 SRUM。

相似文献

1
Identifying interventions that improve medication safety & rational use of medicines in India.识别可提高印度药物安全和合理用药的干预措施。
Indian J Med Res. 2024 May;159(5):410-420. doi: 10.25259/ijmr_945_23.
2
Setting research priorities for maternal, newborn, child health and nutrition in India by engaging experts from 256 indigenous institutions contributing over 4000 research ideas: a CHNRI exercise by ICMR and INCLEN.通过召集来自 256 家本土机构的专家,这些机构贡献了超过 4000 条研究思路,为印度的母婴、新生儿、儿童健康和营养制定研究重点:这是 ICMR 和 INCLEN 进行的 CHNRI 活动。
J Glob Health. 2017 Jun;7(1):011003. doi: 10.7189/jogh.07.011003.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Setting priorities in child health research in India for 2016-2025: a CHNRI exercise undertaken by the Indian Council for Medical Research and INCLEN Trust.2016-2025 年印度儿童健康研究重点制定:印度医学研究理事会和 INCLEN 信托基金开展的 CHNRI 活动。
J Glob Health. 2019 Dec;9(2):020701. doi: 10.7189/jogh.09.020701.
5
Research priorities in Maternal, Newborn, & Child Health & Nutrition for India: An Indian Council of Medical Research-INCLEN Initiative.印度母婴儿童健康与营养研究重点:印度医学研究理事会-INCLEN 倡议。
Indian J Med Res. 2017 May;145(5):611-622. doi: 10.4103/ijmr.IJMR_139_17.
6
Bridging the gap: Using CHNRI to align migration health research priorities in India with local expertise and global perspectives.弥合差距:利用中印研究倡议使印度的移民健康研究重点与本地专业知识和全球视角保持一致。
J Glob Health. 2023 Nov 9;13:04148. doi: 10.7189/jogh.13.04148.
7
Setting health research priorities using the CHNRI method: IV. Key conceptual advances.运用CHNRI方法确定卫生研究重点:四、关键概念进展
J Glob Health. 2016 Jun;6(1):010501. doi: 10.7189/jogh.06.010501.
8
Agreeing on global research priorities for medication safety: an international prioritisation exercise.达成全球药物安全研究重点共识:一项国际优先排序实践。
J Glob Health. 2019 Jun;9(1):010422. doi: 10.7189/jogh.09.010422.
9
Global research priorities to accelerate programming to improve early childhood development in the sustainable development era: a CHNRI exercise.全球研究重点:加速制定方案,在可持续发展时代促进儿童早期发展:CHNRI 行动。
J Glob Health. 2019 Dec;9(3):020703. doi: 10.7189/jogh.09.020703.
10
Stakeholders' perspectives on access-to-medicines policy and research priorities in Latin America and the Caribbean: face-to-face and web-based interviews.利益相关者对拉丁美洲和加勒比地区药品可及性政策和研究重点的看法:面对面和网络访谈。
Health Res Policy Syst. 2014 Jun 25;12:31. doi: 10.1186/1478-4505-12-31.

本文引用的文献

1
Assessment of prescribing pattern of drugs and completeness of prescriptions as per the World Health Organization prescribing indicators in various Indian tertiary care centers: A multicentric study by Rational Use of Medicines Centers-Indian Council of Medical Research network under National Virtual Centre Clinical Pharmacology activity.评估印度各三级医疗中心按照世界卫生组织处方指标的药物处方模式和处方完整性:印度医学研究理事会合理用药中心网络在国家虚拟中心临床药理学活动下进行的一项多中心研究。
Indian J Pharmacol. 2022 Sep-Oct;54(5):321-328. doi: 10.4103/ijp.ijp_976_21.
2
A Delphi consensus study to identify priorities for improving and measuring medication safety for intensive care patients on transfer to a hospital ward.一项德尔菲共识研究,旨在确定改善和衡量 ICU 患者转至医院病房时用药安全的优先事项。
Int J Qual Health Care. 2022 Nov 4;34(4). doi: 10.1093/intqhc/mzac082.
3
Knowledge, Attitude and Practice Survey Regarding High Alert Medication Among Resident Doctors in a Tertiary Care Teaching Hospital in Eastern India.关于印度东部一家三级教学医院住院医师高警示药物认知、态度和实践的调查。
Curr Drug Saf. 2022;17(4):375-381. doi: 10.2174/1574886317666220207123704.
4
Preventable medication harm across health care settings: a systematic review and meta-analysis.在医疗保健环境中可预防的药物伤害:系统评价和荟萃分析。
BMC Med. 2020 Nov 6;18(1):313. doi: 10.1186/s12916-020-01774-9.
5
Decreasing medication errors in four intensive care units of a tertiary care teaching hospital in India using a sensitization programme.在印度一家三级护理教学医院的四个重症监护病房中,通过开展一项宣传计划来减少用药错误。
Natl Med J India. 2019 Jul-Aug;32(4):207-212. doi: 10.4103/0970-258X.291294.
6
Prevalence and Nature of Medication Errors and Medication-Related Harm Following Discharge from Hospital to Community Settings: A Systematic Review.从医院出院到社区环境后药物错误和与药物相关的伤害的发生率和性质:系统评价。
Drug Saf. 2020 Jun;43(6):517-537. doi: 10.1007/s40264-020-00918-3.
7
India's National Action Plan for antimicrobial resistance - An overview of the context, status, and way ahead.印度抗菌药物耐药性国家行动计划——背景、现状及未来方向概述
J Family Med Prim Care. 2019 Jun;8(6):1828-1834. doi: 10.4103/jfmpc.jfmpc_275_19.
8
Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995-2050.全球卫生融资的过去、现在和未来:对 195 个国家 1995 年至 2050 年用于卫生的发展援助、政府、自付费用和其他私人支出的评估。
Lancet. 2019 Jun 1;393(10187):2233-2260. doi: 10.1016/S0140-6736(19)30841-4. Epub 2019 Apr 25.
9
Agreeing on global research priorities for medication safety: an international prioritisation exercise.达成全球药物安全研究重点共识:一项国际优先排序实践。
J Glob Health. 2019 Jun;9(1):010422. doi: 10.7189/jogh.09.010422.
10
The prevalence of medication-related adverse events in inpatients-a systematic review and meta-analysis.住院患者中药物相关不良事件的患病率——一项系统评价和荟萃分析
Eur J Clin Pharmacol. 2017 Dec;73(12):1539-1549. doi: 10.1007/s00228-017-2330-3. Epub 2017 Sep 5.